Artiva Biotherapeutics, Inc. (ARTV) Net margin 2023–2024
Artiva Biotherapeutics, Inc. (ARTV) net profit margin by fiscal year — reported net income divided by reported revenue.
-26045.0%FY2024 · since FY2023: -87.2% → -26045.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -26045.0% | -25957.8 pp |
| FY2023 | -87.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice